Head-to-head · WeighScore
Effecty vs Roen Rx
By GLP-1 ScorecardUpdated
Score comparison
Effecty has the higher recorded score — 83.7/100 to 55.4/100.
Effecty grades higher on WeighScore, our editorial score across cost value, dose & formulation, clinical oversight, labs & monitoring, fulfillment and contract terms. Mid-market pricing offset by brand-name access and LegitScript verification, all 50 states.
We may earn a commission through these links, at no extra cost to you. Commercial relationships affect placement, but never the WeighScore or our editorial findings. See our disclosure.
Factor by factor
These are recorded editorial marks, not a measure of clinical outcomes. Current prices and terms may differ from those used in the marks. See the methodology.
The numbers
Swipe or scroll to compare both providers.
| Metric | Effecty | Roen Rx |
|---|---|---|
| WeighScore | 83.7/100 | 55.4/100 |
| Grade | B | C |
| Site position | #21 | #489 |
| Semaglutide | $160/mo | $151/mo (3-month plan, plus a separate fee, compounded) |
| Tirzepatide | $240/mo | $216/mo (3-month offer, plus a separate fee, compounded) |
| Coverage | All 50 states | Coverage not published |
| Brand-name access | Yes | Yes |
| Oral / sublingual | Not confirmed | Not confirmed |
Site position #21 · B
Strengths
- Brand-name access
- LegitScript-verified, all 50 states
- Both molecules
What to consider
- Higher pricing ($160/$240)
- Injection-only
- Not a value leader
Site position #489 · C
FDAWarning letter issued to Roen Health, Inc. dba RoenRx in June 2026. See the FDA warning-letter database.
Strengths
- Insurance coordination for eligible branded prescriptions
- General membership and separate medication-included bundles
- Dedicated wellness coaching and secure messaging
- Quarterly compounded medication offers, with separate care fees to confirm
What to consider
- Confirm treatment-specific state eligibility and assigned clinician/pharmacy
- Insurance coverage and a $25 copay are not guaranteed
- General membership excludes medication; separate bundles include it with possible higher-dose extras
- Weight-loss coaches are not licensed dietitians or nutritionists
- Full ineligibility-refund advertising differs from general nonrefundable fees; confirm the selected exception
- FDA issued Roen Health, Inc. dba RoenRx a warning letter in June 2026; the letter is public in FDA's warning-letter database
Featured provider
CoreAge Rx
CoreAge Rx scores 89.5/100 (B+). Advertises pricing across doses with no membership fee, but starting-price displays and FAQ payment/refund promises need to be reconciled with the selected plan and refund policy.
Commercial relationships affect this placement. The score comparison above is separate.
Pricing/verification reflect each provider's public disclosures at last grading; the WeighScore is our editorial judgment per the methodology. Prices change — confirm on each provider's site. Not medical advice; see our disclosure.